Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ultromics, a UK-based artificial intelligence tool developer spun out of University of Oxford, closed a $10m round yesterday backed by university venture fund Oxford Sciences Innovation, medical research firm Mayo Clinic and healthcare-focused investment firm Nina Capital. Ultromics develops artificial intelligence-equipped software to automatically analyse imaging scans for signs of coronary artery disease. Its first product, EchoGo Core, has been approved for use in Europe and is pending approval in the US. Ultromics has allied to several partners in the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?